Anne Angelillo‐Scherrer

Author

Also Known As

A Angelillo-Scherrer, A AngelilloScherrer, A Angelillo‐Scherrer, A Scherrer, A. ANGELILLO‐SCHERRER, A. Angelillo-Scherrer, A. Angelillo‐Scherrer, A. Scherrer, A., Angelillo-Scherrer, Angelillo, Anne

214

Publications

6.1K

Citations

H-Index

109

Concepts

All Affiliations

University Hospital of Bern University of Bern University of Lausanne University Hospital of Geneva University Hospital of Zurich

About

Anne Angelillo‐Scherrer is an author at University Hospital of Bern specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	29	3.2K
2	Public Health	9	9	477
3	Health Sciences	4	4	257
4	Natural Sciences	4	4	304
5	Biochemistry	1	1	62

Anne Angelillo‐Scherrer

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Aernout Luttun, Marc Tjwa, Lieve Moons, Nature Medicine AngiogenesisPlgf TreatmentVascular AdaptationVascular SurgeryIschemic Tissues	2002	1.1K
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis Anne Angelillo‐Scherrer, Pablo Garcı́a de Frutos, Cristina Aparicio, Nature Medicine InflammationThrombosisThrombopoiesisBlood PlateletMedicine	2001	436
Cell-derived microparticles in haemostasis and vascular medicine Laurent Burnier, Pierre Fontana, Brenda R. Kwak, Thrombosis and Haemostasis Haemostatic ResponseImmunologyBlood CellExtracellular MicrovesiclesBiomedical Engineering	2009	394
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy Anne Angelillo‐Scherrer, Laurent Burnier, Nathalie Flores, Journal of Clinical Investigation	2005	259
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study Matthias B. Moor, Franziska Suter‐Riniker, Michael P. Horn, The Lancet Rheumatology	2021	208
Red blood cell–derived microparticles isolated from blood units initiate and propagate thrombin generation Olivier Rubin, Julien Delobel, Michel Prudent, Transfusion	2012	144
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests Lars M. Asmis, Lorenzo Alberio, Anne Angelillo‐Scherrer, Thrombosis Research ThrombosisMedicineBioanalysisPharmacologyPhysiology	2011	138
SRP Keeps Polypeptides Translocation-Competent by Slowing Translation to Match Limiting ER-Targeting Sites Asvin KK Lakkaraju, Camille Mary, Anne Angelillo‐Scherrer, Cell Natural SciencesSignal RecognitionMolecular BiologySrp Keeps PolypeptidesProtein Transport	2008	129
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study Nicolas Faller, Andreas Limacher, Marie Méan, The American Journal of Medicine ThrombosisPulmonary EmbolismVenous ThrombosisCardiovascular DiseaseGeriatrics	2016	106
Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization Judith M.E.M. Cosemans, Roger van Kruchten, Servé Olieslagers, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisSignal TransductionBlood PlateletMurine Platelet Activation	2010	102

Page 1